Cajeta, Helen .
HRN: 05-19-48 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2026
CEFUROXIME 500MG (TAB)
05/18/2026
05/25/2026
ORAL
500mg
BID
S/P NSVD With RMLE And Repair; PID
Checking Initial Appropriateness
05/18/2026
METRONIDAZOLE 500MG (TAB)
05/18/2026
05/25/2026
ORAL
500mg
TID
S/P NSVD With RMLE And Repair; PID
Checking Initial Appropriateness